Bluejay Diagnostics Inc. announced changes to its Board of Directors' leadership roles effective August 15, 2025. Donald R. Chase has been appointed as Chairperson of the Board, succeeding Douglas C. Wurth. Mr. Wurth will now serve as Chairperson of the Nominating and Corporate Governance Committee, taking over from Fred S. Zeidman. Mr. Zeidman has been named Chairperson of the Compensation Committee, succeeding Mr. Chase. Mr. Chase continues as Chairperson of the Audit Committee. These appointments follow the Board's regular review of governance assignments.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bluejay Diagnostics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-077600), on August 15, 2025, and is solely responsible for the information contained therein.
Comments